Edgewise Therapeutics has announced the pricing of a $200 million underwritten offering of common stock, identified by the ticker EWTX. Following the announcement, shares of EWTX have experienced volatility, trading at a 25% discount to the offering price. The stock gapped down to $12 after reports of serious adverse events (SAEs) led to investor concerns, particularly as the offering was priced at $20. Additionally, EWTX shares have dropped by 35% despite claims of positive data. In contrast, the Mexican ETF, identified by the ticker EWW, has seen a rise of 3.3%, reflecting a positive market sentiment towards Mexico's economic outlook.